搜索结果: 1-7 共查到“ALZHEIMER DISEASE”相关记录7条 . 查询时间(0.125 秒)
Association of dietary cholesterol and egg intakes with the risk of incident dementia or Alzheimer disease: the Kuopio Ischaemic Heart Disease Risk Factor Study
Alzheimer disease apolipoprotein E4 cholesterol cognitive function,
2018/11/12
Background: There is little information about the associations of intakes of cholesterol and eggs, a major source of dietary cholesterol, with the risk of cognitive decline in general populations or i...
THERAPEUTIC IMPLICATIONS OF COMPUTER MODELS OF BRAIN ACTIVITY FOR ALZHEIMER DISEASE
COMPUTER MODELS
2015/7/31
Neural models of large-scale brain processes help to explain many features of neuropsychological syndromes and psychiatric disease. Two associative memory models useful to understand some aspects of c...
Novel regulation of neuronal genes implicated in Alzheimer disease by microRNA
Alzheimer APP BACE1 microRNA post-transcriptional gene regulation amyloid fetal neurons
2015/5/21
Alzheimer disease (AD) results, in part, from the excess accumulation of the amyloid-β peptide (Aβ) as neuritic plaques in the brain. The short Aβ peptide is derived from a large transmembrane precurs...
Treadmill Running Reverses Cognitive Declines due to Alzheimer Disease
PHYSICAL EXERCISE COGNITIVE FUNCTION ALZHEIMER DISEASE NEUROPATHOLOGY
2017/4/20
Purpose: This study investigated the effect of treadmill running on cognitive declines in the early and advanced stages of Alzheimer disease (AD) in 3xTg-AD mice.
Methods: At 4 months of age, 3xTg-AD...
Prevalence of cerebrospinal fluid Alzheimer disease-like pattern in atypical dementias
CSF Alzheimer Disease Atypical Dementias Frontotemporal Dementia Corticobasal Syndrome Progressive Supranuclear Palsy
2013/1/28
BACKGROUND: Differential diagnosis between Frontotemporal Dementia (FTD), Corticobasal Syndrome (CBS), Progressive Supranuclear Palsy Syndrome (PSP), FTD with motor neuron disease (FTD-MND) is often c...
Alzheimer disease: protective factors
Alzheimer disease nutrition estrogen homocysteine, nonsteroidal antiinflammatory drugs
2016/6/3
Approximately 6–8% of all persons aged >65 y
have Alzheimer disease and the prevalence of the disease is
increasing. Any intervention strategy aimed at decreasing risks or
delaying the onset of the...
Energy expenditure, energy intake, and weight loss in Alzheimer disease
Alzheimer disease energy expenditure, weight loss body composition metabolic rate cachexia dementia
2016/6/3
Alzheimer disease is one of the leading causes
of death among older individuals. Unexplained weight loss and
cachexia are frequent clinical findings in patients with Alzheimer
disease. Thus, it has...